Fenwick & West represented Cardiac Insight, Inc., a University of Washington spinoff biotech company that develops advanced body worn sensing and computing technologies for applications in cardiology, respiratory and other complex disease states, in its $7 million Series B financing and strategic collaboration agreement. The round was led by Welch Allyn and included participation from WRF Capital and other private investors. In addition, Cardiac Insight and Welch Allyn announced that the companies have entered into a strategic collaboration agreement. Under the terms of the agreement, Welch Allyn will have exclusive global distribution rights for certain Cardiac Insight products and technologies.
Cardiac Insight will use the funding to further develop its body worn sensing and computing technologies, expand clinical research and accelerate sales. More information about Cardiac Insights’ $7M Series B financing and strategic collaboration agreement can be obtained from the company press release.
The Fenwick transaction team for the financing was led by corporate partner Bill Bromfield and corporate associate Anna Szygorski. The Fenwick transaction team for the strategic collaboration agreement was led by technology transactions partner Jake Handy.